Plus: The FDA approves Eli Lilly’s new Alzheimer’s treatment. But shares fall as President Biden calls for lower drug prices. J.R. Whalen reports.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices